These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 3987091)

  • 1. Family studies of erythrocyte complement receptor type 1 levels: reduced levels in patients with SLE are acquired, not inherited.
    Walport MJ; Ross GD; Mackworth-Young C; Watson JV; Hogg N; Lachmann PJ
    Clin Exp Immunol; 1985 Mar; 59(3):547-54. PubMed ID: 3987091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activation.
    Ross GD; Yount WJ; Walport MJ; Winfield JB; Parker CJ; Fuller CR; Taylor RP; Myones BL; Lachmann PJ
    J Immunol; 1985 Sep; 135(3):2005-14. PubMed ID: 4020137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low number of complement C3b/C4b receptors (CR1) on erythrocytes from patients with essential mixed cryoglobulinemia, systemic lupus erythematosus and rheumatoid arthritis: relationship with disease activity, anticardiolipin antibodies, complement activation and therapy.
    Corvetta A; Pomponio G; Bencivenga R; Luchetti MM; Spycher M; Spaeth PJ; Danieli G
    J Rheumatol; 1991 Jul; 18(7):1021-5. PubMed ID: 1833542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased C3b receptors (CR1) on erythrocytes from patients with systemic lupus erythematosus.
    Holme E; Fyfe A; Zoma A; Veitch J; Hunter J; Whaley K
    Clin Exp Immunol; 1986 Jan; 63(1):41-8. PubMed ID: 2937582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythrocyte complement receptor type 1 in patients with systemic lupus erythematosus.
    Yen JH; Liu HW; Lin SF; Chen JR; Chen TP
    J Rheumatol; 1989 Oct; 16(10):1320-5. PubMed ID: 2810256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deficiency of the C3b/C4b receptor (CR1) of erythrocytes in systemic lupus erythematosus: analysis of the stability of the defect and of a restriction fragment length polymorphism of the CR1 gene.
    Wilson JG; Wong WW; Murphy EE; Schur PH; Fearon DT
    J Immunol; 1987 Apr; 138(8):2708-10. PubMed ID: 2881967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The rate of loss of CR1 from ageing erythrocytes in vivo in normal subjects and SLE patients: no correlation with structural or numerical polymorphisms.
    Moldenhauer F; Botto M; Walport MJ
    Clin Exp Immunol; 1988 Apr; 72(1):74-8. PubMed ID: 2899464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a soluble form of the C3b/C4b receptor (CR1) in human plasma.
    Yoon SH; Fearon DT
    J Immunol; 1985 May; 134(5):3332-8. PubMed ID: 3156931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythrocyte complement receptor type 1 (CR1) expression and circulating immune complex (CIC) levels in hydralazine-induced SLE.
    Mitchell JA; Batchelor JR; Chapel H; Spiers CN; Sim E
    Clin Exp Immunol; 1987 May; 68(2):446-56. PubMed ID: 2958187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of erythrocyte C4d and complement receptor 1 in systemic lupus erythematosus.
    Manzi S; Navratil JS; Ruffing MJ; Liu CC; Danchenko N; Nilson SE; Krishnaswami S; King DE; Kao AH; Ahearn JM
    Arthritis Rheum; 2004 Nov; 50(11):3596-604. PubMed ID: 15529364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of hypocomplementaemia and low erythrocyte complement receptor type 1 numbers in determining abnormal immune complex clearance in humans.
    Schifferli JA; Ng YC; Paccaud JP; Walport MJ
    Clin Exp Immunol; 1989 Mar; 75(3):329-35. PubMed ID: 2522842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythrocytes transfused into patients with SLE and haemolytic anaemia lose complement receptor type 1 from their cell surface.
    Walport M; Ng YC; Lachmann PJ
    Clin Exp Immunol; 1987 Sep; 69(3):501-7. PubMed ID: 2959411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CR1 on erythrocytes of Brazilian systemic lupus erythematosus patients: the influence of disease activity on expression and ability of this receptor to bind immune complexes opsonized with complement from normal human serum.
    Marzocchi-Machado CM; Alves CM; Azzolini AE; Polizello AC; Carvalho IF; Lucisano-Valim YM
    J Autoimmun; 2005 Dec; 25(4):289-97. PubMed ID: 16289666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced complement receptor 1 (CR1, CD35) transcription in systemic lupus erythematosus.
    Arora V; Verma J; Dutta R; Marwah V; Kumar A; Das N
    Mol Immunol; 2004 Jun; 41(4):449-56. PubMed ID: 15163541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune complexes and erythrocyte CR1 (complement receptor type 1): effect of CR1 numbers on binding and release reactions.
    Ng YC; Schifferli JA; Walport MJ
    Clin Exp Immunol; 1988 Mar; 71(3):481-5. PubMed ID: 2968204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low C3b receptor reactivity on erythrocytes from patients with systemic lupus erythematosus detected by immune adherence hemagglutination and radioimmunoassays with monoclonal antibody.
    Minota S; Terai C; Nojima Y; Takano K; Takai E; Miyakawa Y; Takaku F
    Arthritis Rheum; 1984 Dec; 27(12):1329-35. PubMed ID: 6239627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C3b receptor (CR1) on phagocytic cells from SLE patients: analysis of the defect and familial study.
    Mir A; Porteu F; Levy M; Lesavre P; Halbwachs-Mecarelli L
    Clin Exp Immunol; 1988 Sep; 73(3):461-6. PubMed ID: 2974768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defective complement receptors (CR1 and CR3) on erythrocytes and leukocytes of factor I (C3b-inactivator) deficient patients.
    Porteu F; Fischer A; Descamps-Latscha B; Halbwachs-Mecarelli L
    Clin Exp Immunol; 1986 Nov; 66(2):463-71. PubMed ID: 2949901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C3b receptor (CR1) expression on the polymorphonuclear leukocytes from patients with systemic lupus erythematosus.
    Fyfe A; Holme ER; Zoma A; Whaley K
    Clin Exp Immunol; 1987 Feb; 67(2):300-8. PubMed ID: 2955969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inherited deficiency of erythrocyte complement receptor type 1 does not cause susceptibility to systemic lupus erythematosus.
    Moldenhauer F; David J; Fielder AH; Lachmann PJ; Walport MJ
    Arthritis Rheum; 1987 Sep; 30(9):961-6. PubMed ID: 2959289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.